NRX Pharmaceuticals Inc
Research NRX Pharmaceuticals Inc (NRXP) on Bullrun: market cap USD 123.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNRXP
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 123.00M
- Financial periodQ2 2026
- RevenueUSD 1.10M
- Net income-USD 16.52M
- Free cash flow-USD 9.77M
- Gross margin38.7%
Valuation Snapshot
latest market cap is USD 123.00M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.23M | -USD 28.62M | -USD 14.11M | 58.8% | -1.34 | USD 7.80M | USD 631.00K | -USD 15.94M |
| FY2024 | USD 0 | -USD 25.13M | -USD 10.64M | n/a | -2.36 | USD 1.44M | USD 6.58M | -USD 23.22M |
| FY2023 | USD 0 | -USD 30.15M | -USD 21.66M | n/a | -3.98 | USD 4.60M | USD 18.32M | -USD 11.73M |
| FY2022 | USD 0 | -USD 39.75M | -USD 39.77M | n/a | -0.6 | USD 20.05M | USD 10.53M | USD 7.41M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 123.00M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 86.00M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 32.10M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 39.18M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 75.08M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 281.12M | n/a | n/a | n/a |
About NRX Pharmaceuticals Inc
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NRX Pharmaceuticals Inc's market cap?
NRX Pharmaceuticals Inc's market capitalization is USD 123.00M.
What does NRX Pharmaceuticals Inc do?
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.